Research recommendation(s) from an individual piece of guidance
- Guidance:
- Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings
- Date issued:
Research recommendations coming out of this guidance
- What are the prevalence, risk and protective factors, and course of illness for different combinations of psychosis and coexisting substance misuse (for example, schizophrenia and cannabis misuse or bipolar disorder and alcohol misuse)?
- What risk factors predict the onset of substance misuse in young people with psychosis?
- What and how should training be provided to healthcare professionals working with people with psychosis and substance misuse?
- Is providing treatment for psychosis and substance misuse services within staffed accommodation more cost-effective than a combination of hospital and home treatment?
- What service delivery models allow people with psychosis and coexisting substance misuse to remain living outside hospital?
- Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?
- Are psychosocial interventions clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?
- Are environmental interventions clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?
- Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?
- Is clozapine clinically and cost effective when compared with other pharmacological interventions for people with psychosis and coexisting substance misuse?